Archives: SEC Filing

Bio-Convert Corporate Presentation (8-K), April 1, 2025

Orocidin Corporate Presentation (8-K), March 6, 2025

Corporate Presentation (8-K), January 2, 2025

Quarterly Report, June 30, 2024

Annual Report, March 31, 2024

Quarterly Report, December 31, 2023

Quarterly Report, September 30, 2023

Quarterly Report, June 30, 2023

Annual Report, July 20, 2023

8-K, June 20, 2023